Medpace Holdings Inc vs United States Oil ETF — how do they compare? Medpace Holdings Inc trades at $528.29 (market cap $15.08B), while United States Oil ETF trades at $129.06. Which is the better fit depends on your goals.
| MEDP | USO | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | — |
52-Week High | $620.59 | $152.96 |
52-Week Low | $308.88 | $66.17 |
Enterprise Value | $14.55B | — |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
USO is trading at $125.51, up 1.25% with strong bullish momentum driven by Middle East supply disruptions. Technical indicators show overall bullish sentiment with moving averages supporting the uptrend, though RSI levels suggest potential overbought conditions. Recent news highlights escalating geopolitical tensions in the Strait of Hormuz, pushing oil prices higher and benefiting the fund's performance.
The outlook remains positive as supply constraints and geopolitical risks continue to support oil prices, though overbought technical conditions warrant caution. Key risks include potential conflict de-escalation and OPEC demand adjustments. Current momentum favors continued strength, but volatility remains elevated due to geopolitical developments.
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →